Semeon Tadesse

Semeon Tadesse practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Semeon Tadesse's NPI, 1669008587, was assigned on March 23, 2020. Semeon Tadesse graduated from Ross Univer in 2020. Semeon Tadesse holds Florida license ME160165.

Semeon Tadesse's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Semeon Tadesse's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Semeon Tadesse is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Semeon Tadesse to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Semeon Tadesse practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Semeon Tadesse's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Semeon Tadesse is board certified in internal medicine by the American Board of Internal Medicine. Semeon Tadesse is licensed in Florida.

CMS data shows 451 Medicare services from Semeon Tadesse across 4 procedure codes in 2024, for 180 Medicare patients. Medicare paid $34,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 180 Medicare patients who saw Semeon Tadesse in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Semeon Tadesse's median patient age at 72, with 43% women.

In 2024, Semeon Tadesse wrote 302 Medicare Part D claims for 154 patients. 87% of them were for generic drugs. CMS names the drug for 66 of them, across 5 drugs with 11 or more claims each, at $333 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Semeon Tadesse for performance year 2024, reported as part of a group. Semeon Tadesse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Semeon Tadesse from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $125.

Semeon Tadesse graduated from Ross Univer in 2020.

Semeon Tadesse is in network with 5 carriers, including Cigna, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.